Question · asked by 1 review
Low vs standard dose valganciclovir: Adverse events
- Population
- solid organ transplant recipients
- Intervention
- Low
- Comparison
- standard dose valganciclovir
- Outcome
- Adverse events
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Low vs standard dose valganciclovir Adverse events · solid organ transplant recipients The review found no eligible studies for this question. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (2024) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Low vs high 17ß‐oestradiol dose · young women with Turner syndrome who have completed pubertal induction · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.